药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Pimavanserin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pimavanserin.
Orciprenaline
Tetrodotoxin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tetrodotoxin.
Orciprenaline
APD791
The risk or severity of adverse effects can be increased when Tubocurarine is combined with APD791.
Orciprenaline
Ezogabine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Ezogabine.
Orciprenaline
Iloperidone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Iloperidone.
Orciprenaline
Renzapride
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Renzapride.
Orciprenaline
Flibanserin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Flibanserin.
Orciprenaline
Pagoclone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pagoclone.
Orciprenaline
Bifeprunox
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Bifeprunox.
Orciprenaline
Cilansetron
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cilansetron.
Orciprenaline
Osanetant
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Osanetant.
Orciprenaline
Lorcaserin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lorcaserin.
Orciprenaline
Amineptine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Amineptine.
Orciprenaline
Methaqualone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Methaqualone.
Orciprenaline
Lysergic acid diethylamide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lysergic acid diethylamide.
Orciprenaline
Urethane
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Urethane.
Orciprenaline
Nomifensine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Nomifensine.
Orciprenaline
Nialamide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Nialamide.
Orciprenaline
Methapyrilene
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Methapyrilene.
Orciprenaline
Iproniazid
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Iproniazid.